dabigatran has been researched along with Aortic Valve Stenosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Gawęda, B; Iwaniec, T; Kapelak, B; Kapusta, P; Kopytek, M; Madeja, J; Mazur, P; Natorska, J; Undas, A; Wypasek, E | 1 |
Astell, H; Stewart, RA; White, HD; Young, L | 1 |
2 other study(ies) available for dabigatran and Aortic Valve Stenosis
Article | Year |
---|---|
Effects of rivaroxaban and dabigatran on local expression of coagulation and inflammatory factors within human aortic stenotic valves.
Topics: Aged; Antithrombins; Aortic Valve; Aortic Valve Stenosis; Blood Coagulation Factors; Cells, Cultured; Dabigatran; Factor Xa Inhibitors; Female; Humans; Inflammation Mediators; Male; Middle Aged; Rivaroxaban; Severity of Illness Index; Signal Transduction | 2020 |
Thrombosis on a Mechanical Aortic Valve whilst Anti-coagulated With Dabigatran.
Topics: Aortic Valve; Aortic Valve Stenosis; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Drug Resistance; Echocardiography, Transesophageal; Fibrinolytic Agents; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Intracranial Embolism; Male; Middle Aged; Postoperative Complications; Risk Adjustment; Severity of Illness Index; Thrombosis; Tomography, X-Ray Computed; Treatment Outcome | 2012 |